Diallyl disulfide down‐regulates calreticulin and promotes C/EBPα expression in differentiation of human leukaemia cells. Issue 1 (5th November 2018)
- Record Type:
- Journal Article
- Title:
- Diallyl disulfide down‐regulates calreticulin and promotes C/EBPα expression in differentiation of human leukaemia cells. Issue 1 (5th November 2018)
- Main Title:
- Diallyl disulfide down‐regulates calreticulin and promotes C/EBPα expression in differentiation of human leukaemia cells
- Authors:
- Sun, Jing
Mu, Hongxiang
Yu, Jia
Li, Linwei
Yan, Hongxia
Li, Guoqing
Tan, Hui
Yang, Nanyang
Yang, Xiaoyan
Yi, Lan - Abstract:
- Abstract: Diallyl disulfide (DADS), the main active component of the cancer fighting allyl sulfides found in garlic, has shown potential as a therapeutic agent in various cancers. Previous studies showed DADS induction of HL‐60 cell differentiation involves down‐regulation of calreticulin (CRT). Here, we investigated the mechanism of DADS‐induced differentiation of human leukaemia cells and the potential involvement of CRT and CCAAT enhancer binding protein‐α (C/EBPα). We explored the expression of CRT and C/EBPα in clinical samples (20 healthy people and 19 acute myeloid leukaemia patients) and found that CRT and C/EBPα expressions were inversely correlated. DADS induction of differentiation of HL‐60 cells resulted in down‐regulated CRT expression and elevated C/EBPα expression. In severe combined immunodeficiency mice injected with HL‐60 cells, DADS inhibited the growth of tumour tissue and decreased CRT levels and increased C/EBPα in vivo. We also found that DADS‐mediated down‐regulation of CRT and up‐regulation of C/EBPα involved enhancement of reactive oxidative species. RNA immunoprecipitation revealed that CRT bound C/EBPα mRNA, indicating its regulation of C/EBPα mRNA degradation by binding the UG‐rich element in the 3′ untranslated region of C/EBPα. In conclusion, the present study demonstrates the C/EBPα expression was correlated with CRT expression in vitro and in vivo and the molecular mechanism of DADS‐induced leukaemic cell differentiation.
- Is Part Of:
- Journal of cellular and molecular medicine. Volume 23:Issue 1(2019)
- Journal:
- Journal of cellular and molecular medicine
- Issue:
- Volume 23:Issue 1(2019)
- Issue Display:
- Volume 23, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 23
- Issue:
- 1
- Issue Sort Value:
- 2019-0023-0001-0000
- Page Start:
- 194
- Page End:
- 204
- Publication Date:
- 2018-11-05
- Subjects:
- C/EBPα -- calreticulin -- diallyl disulphide -- differentiation -- human leukaemia cells
Cytology
Medicine
Molecular Biology
Cytologie -- Périodiques
Médecine -- Périodiques
Biologie moléculaire -- Périodiques
Cytology -- Periodicals
Medicine -- Periodicals
Molecular biology -- Periodicals
611.01805 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1582-4934 ↗
http://www.blackwell-synergy.com/loi/jcmm ↗
http://www.usc.edu/hsc/nml/e-resources/info/joucelmm.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jcmm.13904 ↗
- Languages:
- English
- ISSNs:
- 1582-1838
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.005000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9357.xml